Spero therapeutics to present at upcoming investor conferences

Cambridge, mass., nov. 17, 2021 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that ankit mahadevia, m.d., president and chief executive officer of spero therapeutics, will present and be available for one-on-one meetings at the piper sandler 33rd annual virtual healthcare conference and the 4th annual evercore isi healthconx conference, which are taking place virtually, november 29, 2021 through december 2, 2021 and november 30, 2021 through december 2, 2021, respectively. details for the presentations are as follows.
SPRO Ratings Summary
SPRO Quant Ranking